This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Orexigen Therapeutics Inc (OREX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 104.24M 98.12M 78.33M 101.75M
Receivables 2.57M 0.00 0.00 0.00
Inventories 1.20M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 211.33M 178.28M 138.89M 148.72M
Property, Plant & Equipment, Gross 2.92M 2.58M 1.96M 2.14M
Accumulated Depreciation & Depletion 2.06M 1.95M 1.88M 1.70M
Property, Plant & Equipment, Net 857.00K 630.00K 83.00K 439.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 798.00K 1.21M 177.00K 542.00K
Total Non-Current Assets 1.66M 1.84M 260.00K 981.00K
Liabilities & Shareholder Equity
Total Assets 212.98M 180.12M 139.15M 149.70M
Accounts Payable 4.24M 4.79M 3.81M 1.53M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 29.71M 22.85M 25.11M 7.71M
Long Term Debt 83.91M 80.03M 0.00 0.00
Deferred Income Taxes 547.00K 0.00 0.00 0.00
Other Non-Current Liabilities 76.47M 35.38M 38.57M 42.29M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 160.92M 115.41M 38.57M 42.29M
Total Liabilities 190.64M 138.26M 63.68M 49.99M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 22.34M 41.86M 75.47M 99.71M
Common Par 123.00K 105.00K 84.00K 61.00K
Additional Paid In Capital 574.25M 556.24M 512.17M 446.36M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -552.00M -514.48M -436.80M -346.71M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -26.00K -3.00K 15.00K -2.00K
Total Capitalization 106.25M 121.89M 75.47M 99.71M
Total Equity 22.34M 41.86M 75.47M 99.71M
Total Liabilities & Stock Equity 212.98M 180.12M 139.15M 149.70M
Total Common Shares Outstanding 123.46M 104.97M 84.41M 61.29M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 118.24M 96.49M 70.74M 48.27M
Diluted Weighted Shares Outstanding 118.24M 96.49M 70.74M 48.27M
Number of Employees 47 50 41 23
Number of Part-Time Employees 3 1 2 2

OREX Orexigen Therapeutics Inc

Chart of OREX

Analysts Ratings for OREX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 5
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

OREX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs